Current funding opportunities

You are here

We are now accepting applications for the following funding programs:

Committee for Pharmaceutical Development

Deadline
N/A (applications accepted on a continuous basis)

Program overview
The goal of the Committee for Pharmaceutical Development (CPD) is to identify, develop, and commercialize pharmaceutical products by forming networks and fostering dialogue between University of Minnesota researchers and industry experts. The CPD aims to boost the success rate of therapeutic development and commercialization. 

The Office of the Vice President for Research and the Office of the Vice President for Health Sciences serve as the sponsors of the CPD, which includes University staff and external advisors with proven drug-development experience.

The CPD provides guidance and funding, with potential matching funds from philanthropic and industry partners. Funded technologies will have demonstrated persuasive indicators of commercial success and will show potential for improving human health.

Application instructions
Funding request form
Guidance request form
Please submit forms to the Program Manager, Jodi Fenlon Rebuffoni, at fenl0003@umn.edu
Community Research Van

Deadline
N/A (applications accepted on a continuous basis)

Program overview
Researchers can now access CTSI’s Community Research Van, a new mobile health lab designed to help University of Minnesota research teams conduct health studies in the five-state area.

The van is available at no cost to researchers, and features a laptop, space for private interviews, and equipment for measuring height, weight, cholesterol, heart rates, body composition, and blood sugar. Requests to use the van will be accepted on a continuous basis from researchers who wish to conduct studies that address human health issues.

Application instructions

Pediatric Medical Device Translational Grant Program
Deadlines
5/1/15: Mandatory letters of intent (LOI) due by 5pm
7/8/15: Full proposals due by 5pm

Program overview
The Pediatric Medical Device Translational Grant Program supports the development of pediatric medical devices, with the ultimate goal of improving pediatric patient outcomes and quality of life through technology-driven medical solutions. The program’s partners, CTSI’s Office of Discovery and Translation (ODAT) and the Pediatric Device Innovation Consortium (PDIC), will provide funded investigators with work strategy guidance, frequent feedback, and access to comprehensive internal and external services. ODAT and PDIC anticipate funding up to three projects, awarding each a maximum of $50,000 for one year. 

Application instructions
Download the RFA for more information about the application process.

Translational Product Development Fund

Deadlines
5/1/15: Letters of intent due
7/8/15: Full proposals due (by 5pm)
 
Program overview
The Translational Product Development Fund (TPDF) supports the advancement of projects that have the potential to be commercialized, such as projects that aim to form a start-up company or create a license agreement with an established commercial entity. 
 
CTSI and the Mayo Clinic Center for Clinical and Translational Science (CCaTS) established TPDF in conjunction with the Minnesota Partnership for Biotechnology and Medical Genomics (MNP). Ultimately, the program aims to impact the lives of Minnesotans by translating research discoveries into new therapies and treatment approaches for patients.
 
Application instructions 
Download the RFA for more information about the application process.
TTR Core Usage Funding Program

Deadline
Due the 10th of any month
 
Program overview
The ongoing Core Usage Funding Program provides quick access to funding to use the Translational Technologies and Resources (TTR)-designated Core Resources. Nine eligible Core Resources are identified on the RFA. Applicants may request up to $10,000 to use a TTR-designated Core Resource for up to one year.
 
The PI must consult with the appropriate Core Director to discuss feasibility, cost, and a timeline prior to submitting an application. Please review the RFA for additional considerations. This funding supports research to advance medical knowledge that can improve human health.
 
This funding opportunity is open to PIs who hold a faculty-level appointment, Assistant Professor or higher. A direct or clear link to human health or disease must be provided for proposals that include animal models or in vitro culture systems.
 
Applications are due by 5:00 p.m. on the 10th day of any month. Funding decisions are communicated to the PI on the 10th day of the month following the application.
 
Application instructions
Download the RFA for more information about the application process.
 
Find more opportunities and funding resources
  • © 2015 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer. Privacy
  • Last modified on May 22, 2015